Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats.
Eur J Pharmacol
; 910: 174451, 2021 Nov 05.
Article
in En
| MEDLINE
| ID: mdl-34454928
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acetyl-CoA Carboxylase
/
Muscle, Skeletal
/
Diabetes Mellitus, Type 2
/
Alkenes
/
Enzyme Inhibitors
/
Lipid Metabolism
Limits:
Animals
Language:
En
Journal:
Eur J Pharmacol
Year:
2021
Document type:
Article
Country of publication: